No country on earth allows it's pharmaceutical companies as much unregulated use of free market principles in pricing its drugs as the United States. This is particularly controversial, USA Today medical reporter Liz Szabo told KSFR's Dave Marash on HERE & THERE, when the drug in question is an old generic formula, or one on which the expensive research and development was done, not by the company itself, but by university scientists funded by the federal taxpayers.